Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Genitourinary 2CNS 2Tumor-Agnostic 1Plasma cell 1Other 1NET 1Myeloid 1Endocrine 1Dermatologic 1Breast 1

Conditions

Leukemia 2Respiratory Sounds 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hypoxia 1Hodgkin Disease 1Edema 1Dyspnea, Paroxysmal 1Dyspnea 1

Interventions

Cytarabine 905Cyclophosphamide 899fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 460Rituximab 431Methotrexate 419Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 286Vincristine 285Daunorubicin 283Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Furosemide × Other hematologic neoplasm × Clear all
NCT02356159 2025-09-30

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
34 enrolled 18 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

NCT01508260 2013-04-05

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

M.D. Anderson Cancer Center

Phase NA Withdrawn
OtherOther hematologic neoplasm

Hypoxia, Dyspnea, Dyspnea, Paroxysmal, Edema, Leukemia, Respiratory Sounds

Data powered by HemOnc (CC BY 4.0) Colophon âš¡